Claire Brittain

Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections

Enrico Domenici, David Willé, Federica Tozzi et al. · PLoS ONE · 2010 · 349 citations · Full text

Plasma Protein Biomarkers, Neurochemical Biomarkers, Social Sciences +21

Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

Richard Furie, Ian N Bruce, Thomas Dörner et al. · Lara D. Veeken · 2021 · 107 citations · Full text

Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects

Mitul A. Mehta, Anne Schmechtig, Vasileia Kotoula et al. · Psychopharmacology · 2018 · 49 citations

Functional Imaging Response, Healthy Subjects, Neurophysiology +8

Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET

Ana M. Catafau, Marina Álvarez Suárez, Santiago Bullich et al. · NeuroImage · 2009 · 36 citations

Functional Selectivity, Medicine, Within-subject Comparison +5

Dose‐Related Reduction in Bupropion Plasma Concentrations by Ritonavir

Joohyun Park, Marika Vousden, Claire Brittain et al. · The Journal of Clinical Pharmacology · 2010 · 34 citations

Drug Interactions, Dosage Adjustment, Repeat Oral Doses +9